16:01 Dec 20
Shree Ganesh Remedies Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Shree Ganesh Remedies Ltd.
Industry Pharmaceuticals
16:01 Dec 20
Quality
80/100
High Financial Strength
Valuation
35/100
Mid Valuation
Technical
34/100
Technically Bearish
Strength
12
Weakness
6
Opportunity
1
Threats
0
23.02 %
ROE %
16.44 %
ROA %
0.00
EPS
95.07
BVPS
22.32 %
Net Profit Margin
| Mar 2019 | Mar 2020 | Mar 2024 | ||
|---|---|---|---|---|
| Net Sales | 35.31 | 64.02 | 125.9 | |
| Operating Expenses + | 26.57 | 51.51 | 84.08 | |
| Raw Material | 20.48 | 38.31 | 62.33 | |
| Increase Decrease in Cost | -1.98 | -0.39 | -4.88 | |
| Other Manufacturing Expense | 0 | 0 | 0 | |
| Employee Cost | 2.11 | 3.99 | 8.41 | |
| Miscellaneous Expenses | 5.96 | 9.6 | 20.78 | |
| Operating Profit | 8.74 | 12.51 | 41.82 | |
| Other Income | 1.17 | 3.91 | 3.07 | |
| Depreciation | 1.04 | 2.29 | 6.11 | |
| Interest | 0.2 | 0.54 | 0.61 | |
| Profit before tax and exceptio.. | 8.67 | 13.59 | 38.16 | |
| Exceptional Items | 0 | 0 | 0 | |
| PBT | 8.67 | 13.59 | 38.16 | |
| Provision for Taxation | 2.43 | 3.12 | 10.05 | |
| Net Profit | 6.24 | 10.47 | 28.11 | |
| NET Profit after MI | 6.24 | 10.47 | 28.11 | |
| EPS | 6.95 | 11.67 | 22.34 | |
| Operating Profit Margin (%) | 24.75 | 19.54 | 33.22 | |
| Net Profit Margin (%) | 17.67 | 16.35 | 22.33 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Promoter | 70.50 | 69.40 | 69.30 | 69.30 | 69.30 |
| FII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| MF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 29.50 | 30.60 | 30.70 | 30.70 | 30.70 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
